We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

First Episode Psychosis and Pathway to Care in Nordland

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01753284
Recruitment Status : Active, not recruiting
First Posted : December 20, 2012
Last Update Posted : September 28, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
First episode psychosis patients often experiences treatment delay. This reduces their prospects for recovery and makes unnecessary burdens for them and their carers. A better understanding of help seeking intentions is required, and has not been explored in a county like Nordland, Norway, with long distances and challenging access to health services. The purpose of this study is to explore the process of help seeking, including how patients and their careers discover and understand the psychotic symptoms. Research exploring the impact on families mainly focuses on parents` experiences, and there are less studies focusing on experiences and needs of siblings. This study will therefore explore siblings` experiences separate from their parents. Methods will be qualitative interviews with patients, their carers and siblings. Analysis will be influenced by Grounded theory.

Condition or disease
First Episode Psychosis

Study Design

Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Patients and Carers Experiences With First Episode Psychosis and Pathway to Care in Nordland: A Qualitative Study
Study Start Date : January 2013
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Primary Outcome Measures :
  1. Patient experience [ Time Frame: up to 100 weeks ]
  2. Carers experiences [ Time Frame: up to 100 weeks ]
  3. Siblings experiences [ Time Frame: up to 100 weeks ]
  4. Pathway to care [ Time Frame: up to 100 weeks ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   16 Years to 35 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients experiencing first and multiple episode psychosis carers siblings
Criteria

Inclusion Criteria:

  • age 16-35,
  • understand and speak Norwegian
  • able to give consent
  • no learning disabilities

Exclusion Criteria:

More Information

Responsible Party: Nordlandssykehuset HF
ClinicalTrials.gov Identifier: NCT01753284     History of Changes
Other Study ID Numbers: 2012/1650(REK)
First Posted: December 20, 2012    Key Record Dates
Last Update Posted: September 28, 2017
Last Verified: September 2017

Additional relevant MeSH terms:
Psychotic Disorders
Mental Disorders
Schizophrenia Spectrum and Other Psychotic Disorders